The proton therapy systems market size has grown rapidly in recent years. It will grow from $1.17 billion in 2023 to $1.29 billion in 2024 at a compound annual growth rate (CAGR) of 10.5%. The expansion witnessed in the historical period can be ascribed to several factors, including a rise in cancer incidence, heightened awareness among healthcare professionals, the expansion of healthcare infrastructure, increasing healthcare expenditure, and a growing demand for non-invasive treatment alternatives.
The proton therapy systems market size is expected to see rapid growth in the next few years. It will grow to $1.94 billion in 2028 at a compound annual growth rate (CAGR) of 10.6%. The projected growth in the upcoming period is expected to be driven by several factors, notably the escalating burden of cancer, a surge in the adoption of proton therapy, heightened utilization in pediatric oncology cases, a rising preference for outpatient cancer treatment facilities, and an increasing emphasis on environmental sustainability. Key trends anticipated in the forecast period encompass the broader adoption of proton therapy, advancements in technology, integration of artificial intelligence, adoption of pencil beam scanning technology, and the implementation of hypo-fractionated proton therapy protocols.
The rising prevalence of cancer is expected to drive the expansion of the proton therapy systems market in the coming years. Cancer, characterized by abnormal cell growth capable of invading and spreading within the body, is increasingly prevalent due to factors like aging populations, lifestyle shifts, environmental influences, and improved detection and diagnostic methods. Proton therapy systems play a crucial role in cancer treatment by precisely targeting tumors with high radiation doses while minimizing harm to surrounding healthy tissue, potentially reducing side effects and enhancing treatment outcomes. For example, as reported by the American Cancer Society in January 2023, the number of cancer cases rose to 1,958,310 in 2023, marking a 3.16% increase from 1,898,160 in 2021. Consequently, the growing cancer prevalence is propelling the evolution of the proton therapy systems market.
Key players in the proton therapy systems market are concentrating on developing more compact and accessible systems, such as self-shielded proton accelerators, to tackle challenges related to facility space and installation complexity. Self-shielded proton accelerators enhance safety and streamline installation by minimizing external shielding structures typically needed for conventional proton therapy systems. For instance, in October 2022, Mevion Medical Systems unveiled its latest innovation, the MEVION S250-FIT proton therapy system, leveraging its self-shielded proton accelerator. This system, compatible with existing LINAC vaults, is the industry's first comprehensive proton treatment solution supporting rapid integration of technologies like ARC therapy, thus significantly lowering barriers to proton treatment adoption.
In April 2021, Siemens Healthineers, a German medical technology company, acquired Varian Medical Systems Inc. for an undisclosed sum. This acquisition aims to advance cancer treatment efforts and bolster Siemens Healthineers' position in healthcare. Varian Medical Systems Inc., a US-based medical technology firm, specializes in creating and manufacturing proton therapy and radiation devices and software for cancer treatment.
Major companies operating in the proton therapy systems market are Mitsubishi Electric Corporation, Toshiba Corporation, Siemens Healthineers, Koninklijke Philips N.V., GE Healthcare, Sumitomo Heavy Industries Ltd., Hitachi High-Tech Corporation, Acibadem Healthcare Group, Elekta AB, Mirion Technologies, Ion Beam Applications SA, Sirtex Medical Limited, RaySearch Laboratories, Mevion Medical Systems, Sun Nuclear Corporation, ITEL Telecomunicazioni S.r.l, Advanced Oncotherapy plc, Provision Healthcare, Optivus Proton Therapy Inc., Provision Proton Partners International, Danfysik A/S, ProTom International, Best Cyclotron Systems, ACCEL Instruments GmbH, P-Cure Ltd.
North America was the largest region in the proton therapy systems market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the proton therapy systems market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the proton therapy systems market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Proton therapy systems represent advanced medical equipment utilized in radiation therapy for cancer treatment. These systems are designed to deliver proton beams with pinpoint accuracy to tumor locations, thereby minimizing harm to adjacent healthy tissues. In comparison to traditional radiation therapy approaches, proton therapy offers superior treatment precision and decreased adverse effects.
The primary variants of proton therapy systems include those equipped with robotic positioning tables, integrated CT scanners, and integrated PET scanners. Proton therapy systems featuring robotic positioning tables incorporate advanced robotic technology to ensure precise patient positioning during treatment, facilitating the accurate delivery of proton beams to targeted areas. This not only enhances treatment efficacy but also improves patient comfort. These systems are available in single-room and multi-room configurations suitable for treating various types of cancer, such as brain and central nervous system cancer, head and neck cancer, prostate cancer, breast cancer, lung cancer, gastrointestinal cancer, among others. End-users of proton therapy systems encompass hospitals, proton therapy centers, and other medical facilities.
The proton therapy systems market research report is one of a series of new reports that provides proton therapy systems market statistics, including proton therapy systems industry global market size, regional shares, competitors with a proton therapy systems market share, detailed proton therapy systems market segments, market trends and opportunities, and any further data you may need to thrive in the proton therapy systems industry. This proton therapy systems market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The proton therapy systems market consists of sales of cyclotron-based proton therapy systems, synchrotron-based proton therapy systems, and passive scattering systems. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
The proton therapy systems market size is expected to see rapid growth in the next few years. It will grow to $1.94 billion in 2028 at a compound annual growth rate (CAGR) of 10.6%. The projected growth in the upcoming period is expected to be driven by several factors, notably the escalating burden of cancer, a surge in the adoption of proton therapy, heightened utilization in pediatric oncology cases, a rising preference for outpatient cancer treatment facilities, and an increasing emphasis on environmental sustainability. Key trends anticipated in the forecast period encompass the broader adoption of proton therapy, advancements in technology, integration of artificial intelligence, adoption of pencil beam scanning technology, and the implementation of hypo-fractionated proton therapy protocols.
The rising prevalence of cancer is expected to drive the expansion of the proton therapy systems market in the coming years. Cancer, characterized by abnormal cell growth capable of invading and spreading within the body, is increasingly prevalent due to factors like aging populations, lifestyle shifts, environmental influences, and improved detection and diagnostic methods. Proton therapy systems play a crucial role in cancer treatment by precisely targeting tumors with high radiation doses while minimizing harm to surrounding healthy tissue, potentially reducing side effects and enhancing treatment outcomes. For example, as reported by the American Cancer Society in January 2023, the number of cancer cases rose to 1,958,310 in 2023, marking a 3.16% increase from 1,898,160 in 2021. Consequently, the growing cancer prevalence is propelling the evolution of the proton therapy systems market.
Key players in the proton therapy systems market are concentrating on developing more compact and accessible systems, such as self-shielded proton accelerators, to tackle challenges related to facility space and installation complexity. Self-shielded proton accelerators enhance safety and streamline installation by minimizing external shielding structures typically needed for conventional proton therapy systems. For instance, in October 2022, Mevion Medical Systems unveiled its latest innovation, the MEVION S250-FIT proton therapy system, leveraging its self-shielded proton accelerator. This system, compatible with existing LINAC vaults, is the industry's first comprehensive proton treatment solution supporting rapid integration of technologies like ARC therapy, thus significantly lowering barriers to proton treatment adoption.
In April 2021, Siemens Healthineers, a German medical technology company, acquired Varian Medical Systems Inc. for an undisclosed sum. This acquisition aims to advance cancer treatment efforts and bolster Siemens Healthineers' position in healthcare. Varian Medical Systems Inc., a US-based medical technology firm, specializes in creating and manufacturing proton therapy and radiation devices and software for cancer treatment.
Major companies operating in the proton therapy systems market are Mitsubishi Electric Corporation, Toshiba Corporation, Siemens Healthineers, Koninklijke Philips N.V., GE Healthcare, Sumitomo Heavy Industries Ltd., Hitachi High-Tech Corporation, Acibadem Healthcare Group, Elekta AB, Mirion Technologies, Ion Beam Applications SA, Sirtex Medical Limited, RaySearch Laboratories, Mevion Medical Systems, Sun Nuclear Corporation, ITEL Telecomunicazioni S.r.l, Advanced Oncotherapy plc, Provision Healthcare, Optivus Proton Therapy Inc., Provision Proton Partners International, Danfysik A/S, ProTom International, Best Cyclotron Systems, ACCEL Instruments GmbH, P-Cure Ltd.
North America was the largest region in the proton therapy systems market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the proton therapy systems market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the proton therapy systems market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Proton therapy systems represent advanced medical equipment utilized in radiation therapy for cancer treatment. These systems are designed to deliver proton beams with pinpoint accuracy to tumor locations, thereby minimizing harm to adjacent healthy tissues. In comparison to traditional radiation therapy approaches, proton therapy offers superior treatment precision and decreased adverse effects.
The primary variants of proton therapy systems include those equipped with robotic positioning tables, integrated CT scanners, and integrated PET scanners. Proton therapy systems featuring robotic positioning tables incorporate advanced robotic technology to ensure precise patient positioning during treatment, facilitating the accurate delivery of proton beams to targeted areas. This not only enhances treatment efficacy but also improves patient comfort. These systems are available in single-room and multi-room configurations suitable for treating various types of cancer, such as brain and central nervous system cancer, head and neck cancer, prostate cancer, breast cancer, lung cancer, gastrointestinal cancer, among others. End-users of proton therapy systems encompass hospitals, proton therapy centers, and other medical facilities.
The proton therapy systems market research report is one of a series of new reports that provides proton therapy systems market statistics, including proton therapy systems industry global market size, regional shares, competitors with a proton therapy systems market share, detailed proton therapy systems market segments, market trends and opportunities, and any further data you may need to thrive in the proton therapy systems industry. This proton therapy systems market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The proton therapy systems market consists of sales of cyclotron-based proton therapy systems, synchrotron-based proton therapy systems, and passive scattering systems. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
Table of Contents
1. Executive Summary2. Proton Therapy Systems Market Characteristics3. Proton Therapy Systems Market Trends and Strategies32. Global Proton Therapy Systems Market Competitive Benchmarking33. Global Proton Therapy Systems Market Competitive Dashboard34. Key Mergers and Acquisitions in the Proton Therapy Systems Market
4. Proton Therapy Systems Market - Macro Economic Scenario
5. Global Proton Therapy Systems Market Size and Growth
6. Proton Therapy Systems Market Segmentation
7. Proton Therapy Systems Market Regional and Country Analysis
8. Asia-Pacific Proton Therapy Systems Market
9. China Proton Therapy Systems Market
10. India Proton Therapy Systems Market
11. Japan Proton Therapy Systems Market
12. Australia Proton Therapy Systems Market
13. Indonesia Proton Therapy Systems Market
14. South Korea Proton Therapy Systems Market
15. Western Europe Proton Therapy Systems Market
16. UK Proton Therapy Systems Market
17. Germany Proton Therapy Systems Market
18. France Proton Therapy Systems Market
19. Italy Proton Therapy Systems Market
20. Spain Proton Therapy Systems Market
21. Eastern Europe Proton Therapy Systems Market
22. Russia Proton Therapy Systems Market
23. North America Proton Therapy Systems Market
24. USA Proton Therapy Systems Market
25. Canada Proton Therapy Systems Market
26. South America Proton Therapy Systems Market
27. Brazil Proton Therapy Systems Market
28. Middle East Proton Therapy Systems Market
29. Africa Proton Therapy Systems Market
30. Proton Therapy Systems Market Competitive Landscape and Company Profiles
31. Proton Therapy Systems Market Other Major and Innovative Companies
35. Proton Therapy Systems Market Future Outlook and Potential Analysis
36. Appendix
Executive Summary
Proton Therapy Systems Global Market Report 2024 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses on proton therapy systems market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
- Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
- Assess the Russia - Ukraine war’s impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
- Measure the impact of high global inflation on market growth.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for proton therapy systems? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The proton therapy systems market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
- The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.
- The impact of higher inflation in many countries and the resulting spike in interest rates.
- The continued but declining impact of COVID-19 on supply chains and consumption patterns.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:
1) by Type: Proton Therapy Systems With Robotized Positioning Table; Proton Therapy Systems With Integrated CT Scanner; Proton Therapy Systems With Integrated PET Scanner2) by Setup Type: Single Room; Multi Room
3) by Application: Brain and Central Nervous System Cancer; Head and Neck Cancer; Prostate Cancer; Breast Cancer; Lung Cancer; Gastrointestinal Cancer; Other Applications
4) by End-User: Hospitals; Proton Therapy Center; Other End-Users
Key Companies Mentioned: Mitsubishi Electric Corporation; Toshiba Corporation; Siemens Healthineers; Koninklijke Philips N.V.; GE Healthcare
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Mitsubishi Electric Corporation
- Toshiba Corporation
- Siemens Healthineers
- Koninklijke Philips N.V.
- GE Healthcare
- Sumitomo Heavy Industries Ltd.
- Hitachi High-Tech Corporation
- Acibadem Healthcare Group
- Elekta AB
- Mirion Technologies
- Ion Beam Applications SA
- Sirtex Medical Limited
- RaySearch Laboratories
- Mevion Medical Systems
- Sun Nuclear Corporation
- ITEL Telecomunicazioni S.r.l
- Advanced Oncotherapy plc
- Provision Healthcare
- Optivus Proton Therapy Inc.
- Provision Proton Partners International
- Danfysik A/S
- ProTom International
- Best Cyclotron Systems
- ACCEL Instruments GmbH
- P-Cure Ltd.
Methodology
LOADING...
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 175 |
Published | June 2024 |
Forecast Period | 2024 - 2028 |
Estimated Market Value ( USD | $ 1.29 Billion |
Forecasted Market Value ( USD | $ 1.94 Billion |
Compound Annual Growth Rate | 10.6% |
Regions Covered | Global |